Smartphone addiction and associated factors among postgraduate students in an Arabic sample: a cross-sectional study

Autor: Asem A. Alageel, Rayyan A. Alyahya, Yasser A. Bahatheq, Norah A. Alzunaydi, Raed A. Alghamdi, Nader M Alrahili, Roger S. McIntyre, Michelle Iacobucci

Publikováno v: BMC Psychiatry, Vol 21, Iss 1, Pp 1-10 (2021)

Abstract Background Smartphone addiction, as with other behavioral addictions, is associated with social, physical, and mental health issues. In this article, we investigated the prevalence of smartphone addiction among postgraduate students and eval

Externí odkaz: https://doaj.org/article/e285efeea2be49f79d6b5688e2b0efc8

Hematological safety of olanzapine

Autor: Asem A Alageel, Eisha M Gaffas

Publikováno v: Psychiatria i Psychologia Kliniczna, Vol 16, Iss 3, Pp 150-154 (2016)

Olanzapine is an atypical antipsychotic medication, previously expected to be safe in terms of hematological side effects and considered an alternative choice to clozapine in patients who develop hematotoxicities. However, since olanzapine was intr

Externí odkaz: https://doaj.org/article/ae094e55114d4a918b0b9e6a529cebc1

Corrigendum to "Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in major depressive disorder" [J. Affect. Disord.. 238, 2018, pages 228-232].

Autor: Cha DS; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada., Carmona NE; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada., Rodrigues NB; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada., Mansur RB; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada., Lee Y; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Subramaniapillai M; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada., Phan L; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada., Cha RH; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada., Pan Z; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Lee JH; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea., Lee J; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea., Almatham F; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada., Alageel A; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, College of Medicine, Imam Mohammad Ibn Saud Islamic University 'IMSIU', Riyadh, Saudi Arabia., Rosenblat JD; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada., Shekotikhina M; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada., Rong C; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; American University of Integrative Sciences School of Medicine, Sint Maarten, the Netherlands., Harrison J; Alzheimer Center, VU Medical Center, Amsterdam, the Netherlands; Metis Cognition Ltd., Warminster, UK., McIntyre RS; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: Roger.McIntyre@uhn.ca.

Publikováno v: Journal of affective disorders [J Affect Disord] 2023 Nov 01; Vol. 340, pp. 71. Date of Electronic Publication: 2023 Aug 07.

Perceived sleep quality predicts cognitive function in adults with major depressive disorder independent of depression severity.

Autor: Cha DS, Carmona N, Cha RH, Zhou AJ, Subramaniapillai M, Mansur RB, Lee Y, Lee JH, Lee J, Almatham F, Alageel A, Rosenblat JD, Shekotikhina M, Rong C, Harrison J, McIntyre RS; Mood Disorders, Psychopharmacology Unit, University Health Network, Toronto, ON, M5T 2S8 Canada, E-MAIL: roger.mcintyre@uhn.ca.

Publikováno v: Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists [Ann Clin Psychiatry] 2019 Feb; Vol. 31 (1), pp. 17-26.

Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder.

Autor: McIntyre RS; From the Mood Disorders Psychopharmacology Unit, University Health Network, Canada; Institute of Medical Science (Drs. McIntyre and Rosenblat, Ms. Lee, and Mr. Pan), Department of Psychiatry (Drs. McIntyre, Rosenblat, and Mansur), and Department of Pharmacology (Dr. McIntyre), University of Toronto; Paik Institute for Clinical Research, Inje University (Republic of Korea) (Dr. J Lee); Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine (Republic of Korea) (Dr. J-G Lee); Department of Psychiatry, College of Medicine, Imam University (Saudi Arabia) (Dr. Alageel)., Lee Y, Carmona NE, Subramaniapillai M, Cha DS, Lee J, Lee JH, Alageel A, Rodrigues NB, Park C, Ragguett RM, Rosenblat JE, Almatham F, Pan Z, Rong C, Mansur RB

Publikováno v: Harvard review of psychiatry [Harv Rev Psychiatry] 2018 Sep/Oct; Vol. 26 (5), pp. 241-249.